We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Depression in holocaust survivors: profile and treatment outcome in a geriatric day hospital program.
The profile of depressive symptoms and the outcome of treatment in Holocaust Survivors (HS) versus non-Holocaust Survivors (NS), attending a Psychiatric Day Hospital Program for depression, were evaluated retrospectively using a clinical database. Approximately 24% of the study population were Holocaust Survivors (HS). The HS group was more likely to receive a diagnosis of major depressive disorder or episode as one of their diagnoses. The HS group, in particular those survivors who had been in ghettos or in concentration camps, were more likely to be given a diagnosis of post-traumatic stress disorder. Both groups showed improvement from baseline in their ratings of depression on the Hamilton Depression Rating Scale (HDRS) and Geriatric Depression Scale at the time of discharge (p<0.001). However, there were no significant differences between the groups in terms of their ratings of depression either at admission, at discharge or in their degree of improvement. Likewise, there was no significant difference between the groups in the profile of their depression, as per the sub-scales of the HDRS, with the exception that the HS group displayed more 'insight' than the NS group (p=0.002). The NS group scored higher on the Mattis Dementia Rating Scale compared to the HS group (119.1 versus 125.4, p<0.001), even when level of education was covaried; however, language may be an important confound. In conclusion, there was no significant difference in the profile or outcome of depression between groups. However, the HS group was more likely to receive a diagnosis of post-traumatic stress disorder, displayed more 'insight', and appear to differ in their cognitive profile.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app